Fast-acting human insulin - Adocia

Drug Profile

Fast-acting human insulin - Adocia

Alternative Names: BC-222 human insulin; BioChaperone® Human Insulin; BioChaperone® rhInsulin; HinsBet; Hinsbet-U500; HinsBet® U100

Latest Information Update: 09 Nov 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Adocia
  • Class Antihyperglycaemics; Insulins; Pancreatic hormones
  • Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Diabetes mellitus

Highest Development Phases

  • Phase II Type 1 diabetes mellitus
  • Preclinical Type 2 diabetes mellitus

Most Recent Events

  • 27 Oct 2016 Safety and efficacy data from a phase Ib trial in Type-1 diabetes released by Adocia
  • 01 Aug 2016 Adocia completes a phase I/II trial for Type-1 diabetes mellitus in Germany (NCT02739906)
  • 14 Apr 2016 Adocia plans a phase I/II trial for Type-1 diabetes mellitus in Germany (SC) (NCT02739906)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top